Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling.

PubWeight™: 2.05‹?› | Rank: Top 2%

🔗 View Article (PMID 10347172)

Published in J Biol Chem on June 04, 1999

Authors

A Bafico1, A Gazit, T Pramila, P W Finch, A Yaniv, S A Aaronson

Author Affiliations

1: Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New York 10029, USA.

Articles citing this

A Wnt survival guide: from flies to human disease. J Invest Dermatol (2009) 2.91

Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev (2010) 2.28

An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci U S A (2004) 2.28

Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb Perspect Biol (2013) 2.01

Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest (2000) 1.87

Canonical Wnt signaling is critical to estrogen-mediated uterine growth. Mol Endocrinol (2004) 1.76

Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget (2010) 1.71

A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Mol Cell Biol (2003) 1.67

Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum Mol Genet (2008) 1.62

Wnt5a induces simultaneous cortical axon outgrowth and repulsive axon guidance through distinct signaling mechanisms. J Neurosci (2009) 1.59

Existence of the canonical Wnt signaling pathway in the human trabecular meshwork. Invest Ophthalmol Vis Sci (2012) 1.53

c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Mol Cell Biol (2007) 1.50

Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest (2003) 1.42

Targeting metabolic remodeling in glioblastoma multiforme. Oncotarget (2010) 1.42

The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol Cell Biol (2005) 1.39

Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3. Dev Dyn (2006) 1.38

Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol (2008) 1.35

High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A. Cancer Cell (2011) 1.22

Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol (2011) 1.21

Aging of signal transduction pathways, and pathology. Exp Cell Res (2008) 1.16

Wnt pathway-related gene expression in inflammatory bowel disease. Dig Dis Sci (2007) 1.15

Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profiling. Genome Biol (2009) 1.14

Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. J Gastrointest Surg (2008) 1.12

Soluble frizzled-related protein 1 is estrogen inducible in bone marrow stromal cells and suppresses the earliest events in lymphopoiesis. J Immunol (2008) 1.11

Regulation of Wnt/β-catenin signaling within and from osteocytes. Bone (2013) 1.08

Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling. Biochem Biophys Res Commun (2010) 1.07

Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4- and frizzled 7-dependent pathway: role in neovessel formation. Am J Pathol (2007) 1.04

Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease. BMC Syst Biol (2011) 1.02

SFRP1 reduction results in an increased sensitivity to TGF-β signaling. BMC Cancer (2011) 1.02

Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikis. Cancer Cell Int (2009) 0.99

Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling. Cell Signal (2013) 0.99

Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis (2016) 0.97

SFRP4 was overexpressed in colorectal carcinoma. J Cancer Res Clin Oncol (2010) 0.96

A cryptic frizzled module in cell surface collagen 18 inhibits Wnt/beta-catenin signaling. PLoS One (2008) 0.96

Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol (2010) 0.94

Complex and dynamic patterns of Wnt pathway gene expression in the developing chick forebrain. Neural Dev (2009) 0.92

Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int J Clin Exp Pathol (2012) 0.92

Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS One (2012) 0.91

SFRP-4 abrogates Wnt-3a-induced beta-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation. J Mol Signal (2008) 0.91

Increased expression of secreted frizzled-related protein 4 in polycystic kidneys. J Am Soc Nephrol (2008) 0.89

Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer (2009) 0.89

Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer. Br J Cancer (2009) 0.88

The Netrin-related domain of Sfrp1 interacts with Wnt ligands and antagonizes their activity in the anterior neural plate. Neural Dev (2008) 0.87

The Wnt antagonist sFRP1 as a favorable prognosticator in human biliary tract carcinoma. PLoS One (2014) 0.85

Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells. Oncotarget (2015) 0.85

NC1 domain of collagen α3(IV) derived from the basement membrane regulates Sertoli cell blood-testis barrier dynamics. Spermatogenesis (2013) 0.84

sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration. Arch Biochem Biophys (2011) 0.84

Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltration. PLoS One (2013) 0.84

Wnt-frizzled signaling is part of an FGF-induced cascade that promotes lens fiber differentiation. Invest Ophthalmol Vis Sci (2013) 0.84

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. Sci Rep (2015) 0.84

Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma. Virchows Arch (2014) 0.83

Loss of SFRP1 promotes ductal branching in the murine mammary gland. BMC Dev Biol (2012) 0.83

Sexually dimorphic expression of secreted frizzled-related (SFRP) genes in the developing mouse Müllerian duct. Mol Reprod Dev (2006) 0.82

Inhibition of canonical Wnt signaling increases microvascular hemorrhaging and venular remodeling in adult rats. Microcirculation (2010) 0.82

Crosstalk of the Wnt/β-catenin pathway with other pathways in cancer cells. Genes Dis (2016) 0.81

Krüppel-like factor 4, a "pluripotency transcription factor" highly expressed in male postmeiotic germ cells, is dispensable for spermatogenesis in the mouse. Mech Dev (2009) 0.81

Differential gene expression profiling of enriched human spermatogonia after short- and long-term culture. Biomed Res Int (2014) 0.81

Tyrosine-based signal mediates LRP6 receptor endocytosis and desensitization of Wnt/β-catenin pathway signaling. J Biol Chem (2014) 0.81

Association of Wnt2 and sFRP4 expression in the third trimester placenta in women with severe preeclampsia. Reprod Sci (2013) 0.81

Involvement of Wnt signaling pathways in the metamorphosis of the bryozoan Bugula neritina. PLoS One (2012) 0.81

Secreted frizzled related protein 1 (Sfrp1) and Wnt signaling in innervated and denervated skeletal muscle. J Mol Histol (2008) 0.81

Wnt/beta-catenin signaling in embryonic stem cell converted tumor cells. J Transl Med (2012) 0.80

Sizzled is unique among secreted frizzled-related proteins for its ability to specifically inhibit bone morphogenetic protein-1 (BMP-1)/tolloid-like proteinases. J Biol Chem (2012) 0.80

Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules. PLoS One (2008) 0.79

Beta-catenin and epithelial tumors: a study based on 374 oropharyngeal cancers. Biomed Res Int (2014) 0.79

Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat Cancer. Cancers (Basel) (2016) 0.78

Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of Frizzled. J Biol Chem (2015) 0.78

Olfactomedin 4 deletion induces colon adenocarcinoma in Apc(Min/+) mice. Oncogene (2016) 0.76

SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer. BMC Med Genomics (2016) 0.76

An anterior signaling center patterns and sizes the anterior neuroectoderm of the sea urchin embryo. Development (2016) 0.76

Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. Nat Rev Immunol (2016) 0.76

Expression of signaling components in embryonic eyelid epithelium. PLoS One (2014) 0.75

Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma. Mol Med Rep (2016) 0.75

Endogenous DKK1 and FRZB Regulate Chondrogenesis and Hypertrophy in Three-Dimensional Cultures of Human Chondrocytes and Human Mesenchymal Stem Cells. Stem Cells Dev (2016) 0.75

Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a. Int J Biochem Cell Biol (2015) 0.75

Inhibition of Wnt/β-catenin signal is alleviated reactive gliosis in rats with hydrocephalus. Childs Nerv Syst (2015) 0.75

The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1. Mol Cancer (2014) 0.75

Modulating the wnt signaling pathway with small molecules. Protein Sci (2017) 0.75

Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL. BMC Musculoskelet Disord (2017) 0.75

Induction of CXC chemokines in human mesenchymal stem cells by stimulation with secreted frizzled-related proteins through non-canonical Wnt signaling. World J Stem Cells (2015) 0.75

Activation and Inhibition of The Wnt3A Signaling Pathway in Buffalo (Bubalus bubalis) Embryonic Stem Cells: Effects of WNT3A, Bio and Dkk1. Int J Fertil Steril (2015) 0.75

The crystal structure of full-length Sizzled from Xenopus laevis yields insights into Wnt-antagonistic function of secreted frizzled-related proteins. J Biol Chem (2017) 0.75

Articles by these authors

Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol (1969) 11.78

In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26

Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol (1968) 10.54

Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science (1983) 9.06

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (1991) 8.68

A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res (1987) 7.43

Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells. Science (1971) 6.71

Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science (1985) 6.56

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science (1987) 6.36

Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 5.80

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell (1987) 5.11

Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature (1982) 5.11

Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A (1989) 5.10

Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells. J Gen Virol (1971) 5.01

Tyrosine kinase inhibition: an approach to drug development. Science (1995) 4.82

Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science (1989) 4.79

T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature (1982) 4.54

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U S A (1992) 4.50

Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells. Proc Natl Acad Sci U S A (1973) 4.39

Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol (2001) 4.38

Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 4.37

PDGF induction of tyrosine phosphorylation of GTPase activating protein. Nature (1989) 4.36

Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature (1983) 4.34

Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol (2000) 4.33

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A (1989) 4.17

gag Gene of mammalian type-C RNA tumour viruses. Nature (1976) 4.11

Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene (1995) 4.10

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (1996) 4.04

Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science (1968) 4.00

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene (2001) 3.96

Nonproducer clones of murine sarcoma virus transformed BALB-3T3 cells. Virology (1970) 3.85

Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol Cell (1999) 3.73

Separation of murine cellular and murine leukaemia virus DNA polymerases. Nat New Biol (1971) 3.71

Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science (1991) 3.69

Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product. Nature (1991) 3.68

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44

RNA-dependent DNA polymerase activity in five RNA viruses: divalent cation requirements. Proc Natl Acad Sci U S A (1970) 3.25

Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses. Nature (1985) 3.13

Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. J Biol Chem (1994) 3.03

Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor. Nature (1983) 3.01

Oncogenes in solid human tumours. Nature (1982) 3.00

Characterization of murine leukaemia virus-specific DNA present in normal mouse cells. Nat New Biol (1973) 2.98

Endogenous type-C RNA viruses of mammalian cells. Biochim Biophys Acta (1976) 2.95

Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc Natl Acad Sci U S A (1983) 2.95

A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93

Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.93

Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol (1976) 2.82

Isolation of temperature-sensitive mutants of murine leukemia virus. Virology (1972) 2.78

Molecular cloning of integrated simian sarcoma virus: genome organization of infectious DNA clones. Proc Natl Acad Sci U S A (1981) 2.74

Immunological characterization of primate C-type virus reverse transcriptases. Nat New Biol (1972) 2.73

Mouse leukemia virus: "spontaneous" release by mouse embryo cells after long-term in vitro cultivation. Proc Natl Acad Sci U S A (1969) 2.68

Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses. J Virol (1972) 2.65

Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell (1985) 2.59

Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome. Science (1981) 2.51

BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci U S A (1998) 2.50

Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. Proc Natl Acad Sci U S A (1991) 2.48

Nature and distribution of feline sarcoma virus nucleotide sequences. J Virol (1979) 2.47

Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature (1987) 2.46

Properties of clonal lines of murine sarcoma virus transformed Balb-3T3 cells. Virology (1969) 2.40

RNA dependent DNA polymerase activity in mammalian cells. Nature (1971) 2.37

Genetic factors influencing C-type RNA virus induction. J Exp Med (1972) 2.36

Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science (1988) 2.35

Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA. Proc Natl Acad Sci U S A (1981) 2.34

Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science (1988) 2.29

Major pol gene progenitors in the evolution of oncoviruses. Science (1984) 2.28

Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus. Proc Natl Acad Sci U S A (1974) 2.27

Molecular cloning of Moloney murine sarcoma virus: arrangement of virus-related sequences within the normal mouse genome. Proc Natl Acad Sci U S A (1979) 2.27

Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science (1985) 2.23

The 5' untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor. Mol Cell Biol (1988) 2.22

IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science (1993) 2.21

Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology (1987) 2.19

Restriction enzyme analysis of mouse cellular type C viral DNA: emergence of new viral sequences in spontaneous AKR/J lymphomas. Proc Natl Acad Sci U S A (1979) 2.18

Segregation of loci for C-type virus induction in strains of mice with high and low incidence of leukemia. Science (1973) 2.17

Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res (1992) 2.17

BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines. Cell (1983) 2.17

Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci U S A (1998) 2.15

The nucleotide sequence of the uvrD gene of E. coli. Nucleic Acids Res (1984) 2.14

Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem (1999) 2.12

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (1997) 2.12

Distribution of three classes of endogenous type-C RNA viruses among inbred strains of mice. Virology (1975) 2.07

MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc Natl Acad Sci U S A (1990) 2.07

Characterization of temperature-sensitive mutants of murine leukemia virus. Virology (1973) 2.05

Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype. Proc Natl Acad Sci U S A (1983) 2.04

Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science (1987) 2.03

Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours. Nature (1984) 1.99

The transforming gene of Moloney murine sarcoma virus. Nature (1979) 1.98

The BRCA2 gene product functionally interacts with p53 and RAD51. Proc Natl Acad Sci U S A (1998) 1.97

A genetic locus for inducibility of C-type in BALB-c cells: the effect of a nonlinked regulatory gene on detection of virus after chemical activation. Proc Natl Acad Sci U S A (1972) 1.97

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci U S A (1997) 1.96

Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science (1994) 1.96

Murine sarcoma virus transformation of BALB-3T3 cells: lack of dependence on murine leukemia virus. Proc Natl Acad Sci U S A (1970) 1.96

Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem (1994) 1.95